Register Login

Amgen Inc (AMGN)

  • Event
  • Oct. 20, 2022, 13:12 UTC

(10% Negative) AMGEN INC (AMGN) Announces Delay in difference Development Timeline Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review

Full text
Register to leave comments
  • News bot Oct. 3, 2025, 9:40 a.m.

    📋 AMGEN INC (AMGN) - Clinical Trial Update

    Filing Date: 2022-10-20

    Accepted: 2022-10-20 09:12:08

    Event Type: Clinical Trial Update

    Event Details:

    Amgen Inc (AMGN) Announces Clinical Trial Update Amgen Inc (AMGN) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: difference, disease
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Pandemic-Related Challenges, Regulatory Process
    • Collaboration: ChemoCentryx

    🔬 Clinical Development Pipeline (AMGEN INC):

    Product Type Development Stage Therapeutic Area Source
    Standard of Care DRUG Phase PHASE4 Antineutrophil Cytoplasmic Antibody-associated Vasculitis ClinicalTrials.gov
    Prednisone DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Drug: Carfilzomib + Lenalidomide + Dexamethasone DRUG Phase PHASE4 Relapsed Refractory Multiple Myeloma ClinicalTrials.gov
    Any treatment for unresectable HCC as chosen by the physician DRUG Preclinical Carcinoma, Hepatocellular ClinicalTrials.gov
    XGEVA® DRUG Phase PHASE4 Giant Cell Tumor of Bone ClinicalTrials.gov
    Placebo OTHER Phase PHASE3 Thyroid Eye Disease ClinicalTrials.gov
    Teprotumumab BIOLOGICAL Phase PHASE3 Thyroid Eye Disease ClinicalTrials.gov
    Sotorasib DRUG Phase PHASE1 Thoracic Tumors ClinicalTrials.gov
    Pemetrexed DRUG Phase PHASE1 Thoracic Tumors ClinicalTrials.gov
    Pembrolizumab DRUG Phase PHASE1 Thoracic Tumors ClinicalTrials.gov
    Paclitaxel DRUG Phase PHASE1 Thoracic Tumors ClinicalTrials.gov
    Carboplatin DRUG Phase PHASE1 Thoracic Tumors ClinicalTrials.gov
    AMG 193 DRUG Phase PHASE1 Thoracic Tumors ClinicalTrials.gov
    Chemotherapy DRUG Phase PHASE3 Gastric Cancer ClinicalTrials.gov
    Nivolumab DRUG Phase PHASE3 Gastric Cancer ClinicalTrials.gov
    Bemarituzumab DRUG Phase PHASE3 Gastric Cancer ClinicalTrials.gov
    Regorafenib DRUG Phase PHASE3 Colorectal Cancer (CRC) ClinicalTrials.gov
    Trifluridine and Tipiracil DRUG Phase PHASE3 Colorectal Cancer (CRC) ClinicalTrials.gov
    Panitumumab DRUG Phase PHASE3 Colorectal Cancer (CRC) ClinicalTrials.gov
    AMG 305 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Apremilast DRUG Phase PHASE3 Psoriasis ClinicalTrials.gov
    AMG 404 DRUG Phase PHASE1 Small Cell Lung Cancer ClinicalTrials.gov
    Tarlatamab DRUG Phase PHASE1 Small Cell Lung Cancer ClinicalTrials.gov
    Prolia® DRUG Phase PHASE4 Glucocorticoid-induced Osteoporosis ClinicalTrials.gov
    AMG 890 DRUG Phase PHASE1 Cardiovascular Disease ClinicalTrials.gov
    Methotrexate (MTX) DRUG Phase PHASE4 Uncontrolled Gout ClinicalTrials.gov
    Pegloticase BIOLOGICAL Phase PHASE4 Uncontrolled Gout ClinicalTrials.gov
    mFOLFOX6 DRUG Phase PHASE3 Gastric Cancer ClinicalTrials.gov
    ABP 692 DRUG Phase PHASE3 Relapsing-remitting Multiple Sclerosis (RRMS) ClinicalTrials.gov
    Ocrelizumab (EU) DRUG Phase PHASE3 Relapsing-remitting Multiple Sclerosis (RRMS) ClinicalTrials.gov
    Ocrelizumab (US) DRUG Phase PHASE3 Relapsing-remitting Multiple Sclerosis (RRMS) ClinicalTrials.gov
    Olpasiran DRUG Phase PHASE3 Cardiovascular Disease ClinicalTrials.gov
    Efavaleukin alfa DRUG Phase PHASE2 Ulcerative Colitis ClinicalTrials.gov
    Blinatumomab DRUG Phase PHASE2 Phase 2 Study ClinicalTrials.gov
    Maridebart cafraglutide DRUG Phase PHASE3 Heart Failure With Preserved Ejection Fraction ClinicalTrials.gov
    Pembrolizumab (EU) DRUG Phase PHASE3 Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer ClinicalTrials.gov
    Pembrolizumab (US) DRUG Phase PHASE3 Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer ClinicalTrials.gov
    ABP 234 DRUG Phase PHASE3 Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer ClinicalTrials.gov
    Abiraterone DRUG Phase PHASE1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) ClinicalTrials.gov
    Darolutamide DRUG Phase PHASE1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) ClinicalTrials.gov
    Xaluritamig DRUG Phase PHASE1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) ClinicalTrials.gov
    Etoposide DRUG Phase PHASE3 Small-cell Lung Cancer ClinicalTrials.gov
    Durvalumab DRUG Phase PHASE3 Small-cell Lung Cancer ClinicalTrials.gov
    Rocatinlimab DRUG Phase PHASE3 Prurigo Nodularis ClinicalTrials.gov
    Peer Support Program BEHAVIORAL Approved Rheumatoid Arthritis ClinicalTrials.gov
    Bevacizumab-awwb DRUG Phase PHASE3 Metastatic Colorectal Cancer ClinicalTrials.gov
    FOLFIRI Regimen DRUG Phase PHASE3 Metastatic Colorectal Cancer ClinicalTrials.gov
    Cabazitaxel DRUG Phase PHASE3 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov
    Enzalutamide DRUG Phase PHASE3 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov
    Etelcalcetide DRUG Phase PHASE3 Secondary Hyperparathyroidism ClinicalTrials.gov
    Dazodalibep DRUG Phase PHASE3 Sjögren's Syndrome ClinicalTrials.gov
    HZN-1116 DRUG Phase PHASE2 Sjogren's Syndrome ClinicalTrials.gov
    Alendronate DRUG Phase PHASE2 Osteoporosis ClinicalTrials.gov
    Romosozumab DRUG Phase PHASE2 Osteoporosis ClinicalTrials.gov
    Inebilizumab DRUG Phase PHASE2 Systemic Lupus Erythematosus ClinicalTrials.gov
    Talimogene laherparepvec BIOLOGICAL Phase PHASE1 Breast Cancer ClinicalTrials.gov
    Avacopan DRUG Phase PHASE2 Granulomatosis With Polyangiitis ClinicalTrials.gov
    Erenumab 140 mg DRUG Phase PHASE4 Migraine Headache ClinicalTrials.gov
    Erenumab 70 mg DRUG Phase PHASE4 Migraine Headache ClinicalTrials.gov
    AMG 420 DRUG Phase PHASE1 Relapsed and/or Refractory Multiple Myeloma ClinicalTrials.gov
    SOC chemotherapy regimen DRUG Phase PHASE3 Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov
    Low-intensity chemotherapy regimen DRUG Phase PHASE3 Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov
    olverembatinib DRUG Phase PHASE2 Phase II Clinical Trial ClinicalTrials.gov
    bemarituzumab, trifluridine/tipiracil DRUG Phase PHASE2 Metastatic Gastro-esophageal Adenocarcinoma ClinicalTrials.gov
    bemarituzumab, irinotecan DRUG Phase PHASE2 Metastatic Gastro-esophageal Adenocarcinoma ClinicalTrials.gov
    bemarituzumab, paclitaxel, ramucirumab DRUG Phase PHASE2 Metastatic Gastro-esophageal Adenocarcinoma ClinicalTrials.gov
    AMG 509 DRUG Phase PHASE1 Prostate Cancer ClinicalTrials.gov
    Comparator AMG 193 Test Tablet DRUG Phase PHASE1 Advanced MTAP-null Solid Tumors ClinicalTrials.gov
    Docetaxel DRUG Phase PHASE1 Advanced MTAP-null Solid Tumors ClinicalTrials.gov
    Romiplostim DRUG Phase PHASE3 Chemotherapy-induced Thrombocytopenia ClinicalTrials.gov
    ABP 206 DRUG Phase PHASE3 Melanoma ClinicalTrials.gov
    Imlygic DRUG Phase PHASE1 NF1 ClinicalTrials.gov
    AMG 510 DRUG Phase PHASE3 KRAS p, G12c Mutated /Advanced Metastatic NSCLC ClinicalTrials.gov
    Denosumab DRUG Phase PHASE2 Smoldering Multiple Myeloma ClinicalTrials.gov
    Bisphosphonate DRUG Phase PHASE3 Osteogenesis Imperfecta ClinicalTrials.gov
    Atezolizumab DRUG Phase PHASE1 Small Cell Lung Cancer ClinicalTrials.gov
    YL201 DRUG Phase PHASE1 Small Cell Lung Cancer ClinicalTrials.gov
    MEDI9929 BIOLOGICAL Phase PHASE2 Atopic Dermatitis ClinicalTrials.gov
    Background Statin Therapy DRUG Phase PHASE3 Dyslipidemia ClinicalTrials.gov
    Evolocumab BIOLOGICAL Phase PHASE3 Dyslipidemia ClinicalTrials.gov
    Romiplostim (formerly AMG 531) DRUG Approved Hematology ClinicalTrials.gov
    CCX168 DRUG Phase PHASE2 Atypical Hemolytic Uremic Syndrome ClinicalTrials.gov
    Placebo SC DRUG Phase PHASE3 Fractures, Bone ClinicalTrials.gov
    Placebo IV DRUG Phase PHASE3 Fractures, Bone ClinicalTrials.gov
    Zoledronic acid 4 mg DRUG Phase PHASE3 Fractures, Bone ClinicalTrials.gov
    Denosumab 70 mg/mL BIOLOGICAL Phase PHASE3 Fractures, Bone ClinicalTrials.gov
    Autologous stem cell transplant PROCEDURE Phase PHASE2 Untreated CD20-positive Large B-cell Lymphoma ClinicalTrials.gov
    Rituximab + ACVBP regimen plus Pegfilgrastim DRUG Phase PHASE2 Untreated CD20-positive Large B-cell Lymphoma ClinicalTrials.gov
    Oprozomib DRUG Phase PHASE1 Solid Tumors ClinicalTrials.gov
    Placebo for denosumab DRUG Phase PHASE3 Steroid-induced Osteopor, Glucocorticoid-induced Ostepor ClinicalTrials.gov
    Risendronate DRUG Phase PHASE3 Steroid-induced Osteopor, Glucocorticoid-induced Ostepor ClinicalTrials.gov
    Placebo for risendronate DRUG Phase PHASE3 Steroid-induced Osteopor, Glucocorticoid-induced Ostepor ClinicalTrials.gov
    Personalized Patient Counselling BEHAVIORAL Phase PHASE4 Persistence to Enbrel ClinicalTrials.gov
    Cisplatin DRUG Phase PHASE2 Cancer ClinicalTrials.gov
    Dexamethasone DRUG Phase PHASE1 Lymphoma ClinicalTrials.gov
    Carfilzomib DRUG Phase PHASE1 Lymphoma ClinicalTrials.gov
    Bevacizumab DRUG Phase PHASE3 Non-small Cell Lung Cancer Metastatic ClinicalTrials.gov
    ABP 215 DRUG Phase PHASE3 Non-small Cell Lung Cancer Metastatic ClinicalTrials.gov
    saline placebo DRUG Phase PHASE2 Metastatic Breast Cancer ClinicalTrials.gov
    G-CSF DRUG Phase PHASE2 Metastatic Breast Cancer ClinicalTrials.gov
    vinorelbine DRUG Phase PHASE2 Metastatic Breast Cancer ClinicalTrials.gov
    trastuzumab DRUG Phase PHASE2 Metastatic Breast Cancer ClinicalTrials.gov
    Vitamin D DRUG Phase PHASE4 Chronic Kidney Disease ClinicalTrials.gov
    Cinacalcet DRUG Phase PHASE4 Chronic Kidney Disease ClinicalTrials.gov
    5-Fluorouracil DRUG Phase PHASE2 Cancer ClinicalTrials.gov
    Irinotecan DRUG Phase PHASE2 Cancer ClinicalTrials.gov
    Leucovorin DRUG Phase PHASE2 Cancer ClinicalTrials.gov
    Placebo plus PLD DRUG Phase PHASE3 Fallopian Tube Cancer ClinicalTrials.gov
    AMG386 plus PLD DRUG Phase PHASE3 Fallopian Tube Cancer ClinicalTrials.gov
    panitumumab, mytomicin C, 5-FU, radiation DRUG Phase PHASE2 Anal Squamous Cell Carcinoma ClinicalTrials.gov
    Standard Chemotherapy DRUG Phase PHASE3 Cancer ClinicalTrials.gov
    Pegfilgrastim DRUG Phase PHASE3 Cancer ClinicalTrials.gov
    rituximab DRUG Phase PHASE3 Diffuse Large Cell Lymphoma ClinicalTrials.gov
    DMARD Therapy DRUG Phase PHASE4 Rheumatoid Arthritis ClinicalTrials.gov
    etanercept DRUG Phase PHASE4 Rheumatoid Arthritis ClinicalTrials.gov
    Radiation Therapy RADIATION Phase PHASE2 Cancer of Head ClinicalTrials.gov
    Cytoxan DRUG Phase PHASE2 Bone Cancer ClinicalTrials.gov
    Doxorubicin DRUG Phase PHASE2 Bone Cancer ClinicalTrials.gov
    Temozolomide DRUG Phase PHASE2 Bone Cancer ClinicalTrials.gov
    Vincristine DRUG Phase PHASE2 Bone Cancer ClinicalTrials.gov
    AMG 386 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    AMG 386 + Paclitaxel DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Etanercept / Autoinjector A DRUG Phase PHASE3 Rheumatoid Arthritis ClinicalTrials.gov
    Intensive Care OTHER Approved Psoriatic Arthritis (PsA) ClinicalTrials.gov
    RAD001 + AMG479 DRUG Phase PHASE1 Neoplasm Metastases ClinicalTrials.gov
    sorafenib tosylate DRUG Phase EARLY_PHASE1 Kidney Cancer ClinicalTrials.gov
    Etanercept via Autoinjector B DRUG Phase PHASE4 Rheumatoid Arthritis ClinicalTrials.gov
    Etanercept via Autoinjector A DRUG Phase PHASE4 Rheumatoid Arthritis ClinicalTrials.gov
    Placebo (for denosumab) DRUG Phase PHASE4 Hip Osteoarthritis ClinicalTrials.gov
    Denosumb DRUG Phase PHASE4 Hip Osteoarthritis ClinicalTrials.gov
    High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Methotrexate DRUG Phase PHASE4 Moderate to Severe Rheumatoid Arthritis ClinicalTrials.gov
    peripheral stem cell collection PROCEDURE Phase PHASE1 Diffuse Large B-cell Lymphoma (DLBCL) ClinicalTrials.gov
    Lenalidomide DRUG Phase PHASE1 Diffuse Large B-cell Lymphoma (DLBCL) ClinicalTrials.gov
    Cytarabine DRUG Phase PHASE1 Diffuse Large B-cell Lymphoma (DLBCL) ClinicalTrials.gov
    Everolimus DRUG Phase PHASE1 Colorectal Cancer ClinicalTrials.gov
    AMG 162 DRUG Phase PHASE3 Low Bone Mineral Density ClinicalTrials.gov
    Arm 2- Dose Expansion DRUG Phase PHASE1 Cancer ClinicalTrials.gov
    Arm 1- Dose Escalation DRUG Phase PHASE1 Cancer ClinicalTrials.gov
    Carfilzomib and Dexamethasone DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Adalimumab BIOLOGICAL Phase PHASE3 Arthritis, Rheumatoid ClinicalTrials.gov
    ABP 501 BIOLOGICAL Phase PHASE3 Arthritis, Rheumatoid ClinicalTrials.gov
    AMG 102 and erlotinib DRUG Phase PHASE1 Carcinoma, Non-Small-Cell Lung ClinicalTrials.gov
    [¹⁴C]Etelcalcetide DRUG Phase PHASE1 Secondary Hyperparathyroidism in Patients With ESRD on Hemodialysis ClinicalTrials.gov
    Physician Survey OTHER Preclinical Solid Tumours ClinicalTrials.gov
    Traditional Vitamin D Therapy DRUG Phase PHASE4 Hyperparathyroidism, Secondary ClinicalTrials.gov
    AMG 167 DRUG Phase PHASE1 Osteopenia ClinicalTrials.gov
    Best Supportive Care (BSC) OTHER Phase PHASE3 Metastatic Colorectal Cancer ClinicalTrials.gov
    Epirubicin, Cisplatin, Capecitabine DRUG Phase PHASE2 Stomach Neoplasms ClinicalTrials.gov
    Epirubicin, Cisplatin, Capecitabine, Panitumumab DRUG Phase PHASE2 Stomach Neoplasms ClinicalTrials.gov
    Group B: Carfilzomib & IMiD containing regimen. DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Group A: Carfilzomib & Non-IMiD Regimen DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Placebo to Atorvastatin DRUG Phase PHASE3 Primary Hyperlipidemia and Mixed Dyslipidemia ClinicalTrials.gov
    Placebo to Evolocumab DRUG Phase PHASE3 Primary Hyperlipidemia and Mixed Dyslipidemia ClinicalTrials.gov
    Atorvastatin DRUG Phase PHASE3 Primary Hyperlipidemia and Mixed Dyslipidemia ClinicalTrials.gov
    AMG 479 DRUG Phase PHASE2 Neuroendocrine Tumor ClinicalTrials.gov
    Palifermin DRUG Phase PHASE3 Head and Neck Cancer ClinicalTrials.gov
    Cyclophosphamide DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    AMG 282 Matching Placebo DRUG Phase PHASE1 Asthma ClinicalTrials.gov
    AMG 282 DRUG Phase PHASE1 Asthma ClinicalTrials.gov
    AMG 954/Panitumumab DRUG Phase PHASE1 Oncology ClinicalTrials.gov
    zoledronic acid DRUG Phase PHASE3 Bone Metastases ClinicalTrials.gov
    Standard Fractionation Radiotherapy RADIATION Phase PHASE2 Head and Neck Cancer ClinicalTrials.gov
    60 mg denosumab DRUG Phase PHASE3 Low Bone Mass ClinicalTrials.gov
    Ferric carboxymaltose DRUG Phase PHASE3 Tubular Breast Cancer Stage II ClinicalTrials.gov
    Pertuzumab DRUG Phase PHASE3 Tubular Breast Cancer Stage II ClinicalTrials.gov
    Epirubicin DRUG Phase PHASE3 Tubular Breast Cancer Stage II ClinicalTrials.gov
    non-pegylated liposomal doxorubicin DRUG Phase PHASE3 Tubular Breast Cancer Stage II ClinicalTrials.gov
    Amgen 386 DRUG Phase PHASE1 Glioblastoma Multiforme ClinicalTrials.gov
    AMG 337 DRUG Phase PHASE2 Stomach Neoplasms ClinicalTrials.gov
    Sorafenib (Nexavar, BAY43-9006) DRUG Phase PHASE3 Thyroid Neoplasms ClinicalTrials.gov
    2=Clobetasol propionate foam DRUG Phase PHASE3 Psoriasis ClinicalTrials.gov
    1=Etanercept DRUG Phase PHASE3 Psoriasis ClinicalTrials.gov
    AMG 108 BIOLOGICAL Phase PHASE2 Diabetes Mellitus ClinicalTrials.gov
    r-metHuLeptin DRUG Phase PHASE2 HAART-induced Lipodystrophy and Metabolic Syndrome ClinicalTrials.gov
    AMG 162 / Denosumab DRUG Phase PHASE3 Breast Cancer ClinicalTrials.gov
    AGT-182 DRUG Phase PHASE1 Mucopolysaccharidosis II ClinicalTrials.gov
    AMG 745 3.0 mg/kg DRUG Phase PHASE2 Age-associated Muscle Loss ClinicalTrials.gov
    AMG 745 1.0 mg/kg DRUG Phase PHASE2 Age-associated Muscle Loss ClinicalTrials.gov
    AMG 745 0.3 mg/kg DRUG Phase PHASE2 Age-associated Muscle Loss ClinicalTrials.gov
    Melphalan DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    AMG 319 DRUG Phase PHASE1 Cancer ClinicalTrials.gov
    Loratadine DRUG Phase PHASE2 Bone Pain in Stage I - III Breast Cancer ClinicalTrials.gov
    Naproxen DRUG Phase PHASE2 Bone Pain in Stage I - III Breast Cancer ClinicalTrials.gov
    AGT-181 DRUG Phase PHASE1 Mucopolysaccharidosis I ClinicalTrials.gov
    Matching Placebo DRUG Phase PHASE1 Lupus Arthritis, Systemic Lupus Erythematosus ClinicalTrials.gov
    AMG 557 DRUG Phase PHASE1 Lupus Arthritis, Systemic Lupus Erythematosus ClinicalTrials.gov
    Quality Improvement Intervention BEHAVIORAL Approved Cardiovascular Diseases ClinicalTrials.gov
    AMG 706 DRUG Phase PHASE2 Advanced Non-squamous NSCLC ClinicalTrials.gov
    Cisplatin, 5-FU DRUG Phase PHASE3 Esophageal Squamous Cell Cancer ClinicalTrials.gov
    Decitabine DRUG Phase PHASE2 MDS ClinicalTrials.gov
    Azacitidine DRUG Phase PHASE2 MDS ClinicalTrials.gov
    AMG 531 (Romiplostim) BIOLOGICAL Phase PHASE2 MDS ClinicalTrials.gov
    Darbepoetin alfa DRUG Phase PHASE3 MDS ClinicalTrials.gov
    Best Supportive Care DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Intensity Modulated Radiation Therapy RADIATION Phase PHASE1 Squamous Cell Carcinoma of the Head and Neck ClinicalTrials.gov
    Midazolam DRUG Phase PHASE1 Postmenopausal Osteoporosis ClinicalTrials.gov
    Epoetin alfa DRUG Phase PHASE4 Renal Insufficiency, Chronic ClinicalTrials.gov
    Irinotecan Based Chemotherapy DRUG Phase PHASE3 Colorectal Cancer ClinicalTrials.gov
    Oxaliplatin Based Chemotherapy DRUG Phase PHASE3 Colorectal Cancer ClinicalTrials.gov
    Denosumab CP2 DRUG Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Denosumab CP4 DRUG Phase PHASE1 Healthy Volunteer ClinicalTrials.gov
    Topical agents DRUG Phase PHASE3 Psoriasis ClinicalTrials.gov
    AMG 386 Placebo DRUG Phase PHASE3 Fallopian Tube Cancer ClinicalTrials.gov
    Filgrastim DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov
    Herceptin DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov
    cyclophosphamide, methotrexate, fluorouracil, PEG-filgrastim DRUG Approved Breast Cancer ClinicalTrials.gov
    Sorafenib DRUG Phase PHASE1 Advanced Hepatocellular Carcinoma ClinicalTrials.gov
    teriparatide DRUG Phase PHASE2 Osteoporosis ClinicalTrials.gov
    Sunitinib DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    MEDI9929, 140 mg DRUG Phase PHASE1 Asthma ClinicalTrials.gov
    Panitumumab + FOLFOX (no-DP) DRUG Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    Panitumumab + FOLFOX (DP) DRUG Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    Erenumab DRUG Phase PHASE2 Stable Angina ClinicalTrials.gov
    Denosumab (CP4) DRUG Phase PHASE3 Postmenopausal Osteoporosis ClinicalTrials.gov
    Denosumab (CP2) DRUG Phase PHASE3 Postmenopausal Osteoporosis ClinicalTrials.gov
    Imaging OTHER Phase PHASE2 Metastatic Breast Cancer ClinicalTrials.gov
    Panitumumab+FOLFIRI DRUG Phase PHASE2 Colorectal Cancer ClinicalTrials.gov
    Panitumumab+FOLFOX-4 DRUG Phase PHASE2 Colorectal Cancer ClinicalTrials.gov
    cyclosporine DRUG Phase PHASE2 AML ClinicalTrials.gov
    fludarabine DRUG Phase PHASE2 AML ClinicalTrials.gov
    No intervention OTHER Preclinical Non-Hodgkin's Lymphoma ClinicalTrials.gov
    AGT-181 (HIRMAb-IDUA) DRUG Phase PHASE1 Mucopolysaccharidosis I ClinicalTrials.gov
    VIB4920 DRUG Phase PHASE2 Rheumatoid Arthritis ClinicalTrials.gov
    nbUVB phototherapy PROCEDURE Phase PHASE2 Vitiligo ClinicalTrials.gov
    AMG 714 BIOLOGICAL Phase PHASE2 Vitiligo ClinicalTrials.gov
    Omalizumab BIOLOGICAL Phase PHASE2 Chronic Spontaneous Urticaria ClinicalTrials.gov
    Tezepelumab Dose 2 BIOLOGICAL Phase PHASE2 Chronic Spontaneous Urticaria ClinicalTrials.gov
    Tezepelumab Dose 1 BIOLOGICAL Phase PHASE2 Chronic Spontaneous Urticaria ClinicalTrials.gov
    None, standard chemotherapy only OTHER Phase PHASE3 Lung Cancer Non-small Cell Stage IV ClinicalTrials.gov
    Famotidine DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov
    Omeprazole DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov
    Haplo-Mismatched Cell Therapy (HMCT) OTHER Phase PHASE1 B-Cell Acute Lymphoblastic Leukaemia ClinicalTrials.gov
    Consolidation with 4 cycles of CarCyDex DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Autologous Stem Cell Transplant (ASCT) PROCEDURE Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    AMG 340 DRUG Phase PHASE1 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov
    CCX354-C DRUG Phase PHASE2 Rheumatoid Arthritis ClinicalTrials.gov
    CCX-354-C DRUG Phase PHASE2 Rheumatoid Arthritis ClinicalTrials.gov
    CCX 354-C DRUG Phase PHASE1 Rheumatoid Arthritis ClinicalTrials.gov
    Anti PD-1/L1 DRUG Phase PHASE1 KRAS p.G12C Mutant Advanced Solid Tumors ClinicalTrials.gov
    VIB1116 DRUG Phase PHASE1 Dendritic Cell -Mediated Rheumatic Diseases ClinicalTrials.gov
    Rocatinlimab vial injection DRUG Phase PHASE1 Atopic Dermatitis ClinicalTrials.gov
    Moxifloxacin DRUG Phase PHASE1 Basic Science ClinicalTrials.gov
    Current Wearable Heatlth Monitoring System (CWHMS) DEVICE Phase PHASE4 B-precursor Acute Lymphoblastic Leukemia ClinicalTrials.gov
    self-directed Healing Circuits™ curriculum BEHAVIORAL Approved Crohn Disease (CD) ClinicalTrials.gov
    Healing Circuits™ sessions BEHAVIORAL Approved Crohn Disease (CD) ClinicalTrials.gov
    Itraconazole DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov
    placebo solution (10% dextrose) DRUG Phase PHASE2 Hepatic Encephalopathy ClinicalTrials.gov
    sodium phenylacetate and sodium benzoate injection 10% / 10% DRUG Phase PHASE2 Hepatic Encephalopathy ClinicalTrials.gov
    Ipilimumab DRUG Phase PHASE2 Colon Cancer ClinicalTrials.gov
    TAP® Micro Select Device (Touch Activated Phlebotomy) DEVICE Preclinical Obesity ClinicalTrials.gov
    Metformin DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    CCX282-B DRUG Phase PHASE2 Celiac Disease ClinicalTrials.gov
    CCX140-B DRUG Phase PHASE2 Diabetic Nephropathy ClinicalTrials.gov
    AMG 133 DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov
    AMG 691 DRUG Phase PHASE1 Asthma ClinicalTrials.gov
    erenumab-aooe DRUG Preclinical Migraine ClinicalTrials.gov
    Placebo for Rozibafusp Alfa DRUG Phase PHASE2 Systemic Lupus Erythematosus (SLE) ClinicalTrials.gov
    Rozibafusp Alfa DRUG Phase PHASE2 Systemic Lupus Erythematosus (SLE) ClinicalTrials.gov
    MP-376 DRUG Phase PHASE2 Chronic Obstructive Pulmonary Disease ClinicalTrials.gov
    Early Intervention BEHAVIORAL Approved Cardiovascular Diseases ClinicalTrials.gov
    Ivabradine DRUG Phase PHASE4 Heart Failure ClinicalTrials.gov
    MTX/ARA-C DRUG Phase PHASE2 B-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Mini-CVD DRUG Phase PHASE2 B-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    HZT-501 DRUG Phase PHASE3 Osteoarthritis ClinicalTrials.gov
    Talimogene Laherparepvec (T-VEC) DRUG Phase PHASE2 Sarcoma ClinicalTrials.gov
    Aflibercept DRUG Phase PHASE3 Chorioretinal Vascular Disease ClinicalTrials.gov
    ABP 938 DRUG Phase PHASE3 Chorioretinal Vascular Disease ClinicalTrials.gov
    AMG 410 DRUG Phase PHASE1 KRAS Altered Advanced or Metastatic Solid Tumors ClinicalTrials.gov
    AMG 794 DRUG Phase PHASE1 Non-squamous Non-small Cell Lung Cancer ClinicalTrials.gov
    RP103 DRUG Phase PHASE3 Cystinosis ClinicalTrials.gov
    dasatinib DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Drug: Carfilzomib + Dexamethasone DRUG Phase PHASE4 Relapsed Refractory Multiple Myeloma ClinicalTrials.gov
    FOLFOX regimen DRUG Phase PHASE3 Colorectal Cancer ClinicalTrials.gov
    CRS Mitigation Strategies DRUG Phase PHASE1 Small Cell Lung Carcinoma ClinicalTrials.gov
    Gemcitabine DRUG Phase PHASE1 Anatomic Stage III Breast Cancer AJCC v8 ClinicalTrials.gov
    Nab paclitaxel DRUG Phase PHASE1 Anatomic Stage III Breast Cancer AJCC v8 ClinicalTrials.gov
    Tamoxifen DRUG Phase PHASE1 Anatomic Stage III Breast Cancer AJCC v8 ClinicalTrials.gov
    Letrozole DRUG Phase PHASE1 Anatomic Stage III Breast Cancer AJCC v8 ClinicalTrials.gov
    Fulvestrant DRUG Phase PHASE1 Anatomic Stage III Breast Cancer AJCC v8 ClinicalTrials.gov
    Exemestane DRUG Phase PHASE1 Anatomic Stage III Breast Cancer AJCC v8 ClinicalTrials.gov
    Anastrozole DRUG Phase PHASE1 Anatomic Stage III Breast Cancer AJCC v8 ClinicalTrials.gov
    Placebo Alendronate DRUG Phase PHASE2 Osteoporosis, Post-menopausal ClinicalTrials.gov
    Placebo Romosozumab DRUG Phase PHASE2 Osteoporosis, Post-menopausal ClinicalTrials.gov
    Alendronate (Fosamax) DRUG Phase PHASE2 Osteoporosis, Post-menopausal ClinicalTrials.gov
    Lp(a) Screening OTHER Approved Atherosclerotic Cardiovascular Disease ClinicalTrials.gov
    AMG 176 DRUG Phase PHASE1 Relapsed or Refractory Multiple Myeloma ClinicalTrials.gov
    Cystagon® DRUG Phase PHASE3 Cystinosis ClinicalTrials.gov
    Care Champion Intervention OTHER Approved ASCVD ClinicalTrials.gov
    Warfarin DRUG Phase EARLY_PHASE1 Atopic Dermatitis ClinicalTrials.gov
    Metoprolol DRUG Phase EARLY_PHASE1 Atopic Dermatitis ClinicalTrials.gov
    MP-376 (Levofloxacin solution for Inhalation) DRUG Phase PHASE1 Cystic Fibrosis ClinicalTrials.gov
    Cysteamine Bitartrate Delayed-release Capsules DRUG Phase PHASE3 Cystinosis ClinicalTrials.gov
    Hypofractionated Radiotherapy RADIATION Phase PHASE2 Melanoma ClinicalTrials.gov
    TALIMOGENE LAHERPAREPVEC (TVEC) DRUG Phase PHASE2 Melanoma ClinicalTrials.gov
    Daunorubicin DRUG Phase PHASE1 Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov
    6-Mercaptopurine DRUG Phase PHASE1 Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov
    Intrathecal Triple Therapy (Intrathecal Cytarabine, Hydrocortisone, and Methotrexate) DRUG Phase PHASE1 Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov
    Intrathecal (IT) Methotrexate DRUG Phase PHASE1 Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov
    PEG-asparaginase DRUG Phase PHASE1 Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov
    Mitoxantrone DRUG Phase PHASE1 Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov
    Prolia DRUG Phase PHASE4 Osteoporosis ClinicalTrials.gov
    Ibuprofen DRUG Phase PHASE3 Peptic Ulcer ClinicalTrials.gov
    UPLIZNA DRUG Preclinical Neuromyelitis Optica Spectrum Disorder ClinicalTrials.gov
    800 mg ibuprofen/26.6 mg famotidine DRUG Phase PHASE4 Juvenile Idiopathic Arthritis ClinicalTrials.gov
    Injection of TVEC into target lesions 2wks after 3rd injection DRUG Phase PHASE2 Squamous Cell Carcinoma ClinicalTrials.gov
    Injection of TVEC into target lesions 2wks after 2nd injection DRUG Phase PHASE2 Squamous Cell Carcinoma ClinicalTrials.gov
    Injection of TVEC into target lesions 3wks after 1st injection DRUG Phase PHASE2 Squamous Cell Carcinoma ClinicalTrials.gov
    Injection of TVEC into target lesions - week 1-2 DRUG Phase PHASE2 Squamous Cell Carcinoma ClinicalTrials.gov
    Erenumab Prefilled Syringe DRUG Phase PHASE4 Facial Pain ClinicalTrials.gov
    Placebos DRUG Phase PHASE2 Acute Coronary Syndrome ClinicalTrials.gov
    T-VEC DRUG Phase PHASE2 Melanoma Stage III ClinicalTrials.gov
    VIB9600 BIOLOGICAL Phase PHASE1 Safety Issues ClinicalTrials.gov
    interferon γ-1b DRUG Phase PHASE3 Friedreich's Ataxia ClinicalTrials.gov
    standard of care second-line chemotherapy (FOLFIRI) DRUG Phase PHASE2 Advanced Neuroendocrine Carcinomas of The Digestive System ClinicalTrials.gov
    RAYOS (delayed-release prednisone) DRUG Preclinical Rheumatoid Arthritis ClinicalTrials.gov
    Erenumab Dose 3 DRUG Phase PHASE3 Migraine ClinicalTrials.gov
    Erenumab Dose 2 DRUG Phase PHASE3 Migraine ClinicalTrials.gov
    Erenumab Dose 1 DRUG Phase PHASE3 Migraine ClinicalTrials.gov
    Observation OTHER Preclinical Multiple Myeloma ClinicalTrials.gov
    AMG 701 DRUG Preclinical None ClinicalTrials.gov
    Blood Red Cell Transfusion PROCEDURE Phase PHASE3 Myelodysplastic Syndrome ClinicalTrials.gov
    Darbepoetin alpha DRUG Phase PHASE3 Myelodysplastic Syndrome ClinicalTrials.gov
    AMG 786 DRUG Phase PHASE1 Obesity ClinicalTrials.gov
    Daxdilimab DRUG Phase PHASE2 Idiopathic Inflammatory Myositis ClinicalTrials.gov
    Amrubicin DRUG Phase PHASE3 Small Cell Lung Cancer (SCLC) ClinicalTrials.gov
    Topotecan DRUG Phase PHASE3 Small Cell Lung Cancer (SCLC) ClinicalTrials.gov
    Lurbinectedin DRUG Phase PHASE3 Small Cell Lung Cancer (SCLC) ClinicalTrials.gov
    IDE397 DRUG Phase PHASE1 MTAP-null Non-Small-Cell Lung Cancer ClinicalTrials.gov
    Cysteamine Bitartrate DRUG Phase PHASE2 Inherited Mitochondrial Disease, Including Leigh Syndrome ClinicalTrials.gov
    IV Placebo DRUG Phase PHASE3 Myasthenia Gravis ClinicalTrials.gov
    Carfilzomib, Lenalidomide, Dexamethasone, Belantamab Mafodotin DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Usual Care OTHER Approved Hip Fractures ClinicalTrials.gov
    Otago Exercise Program BEHAVIORAL Approved Hip Fractures ClinicalTrials.gov
    HZN-825 DRUG Phase PHASE2 Idiopathic Pulmonary Fibrosis ClinicalTrials.gov
    AMG 994 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Sequential Radiation therapy RADIATION Phase PHASE1 Melanoma ClinicalTrials.gov
    Concurrent Radiation Therapy RADIATION Phase PHASE1 Melanoma ClinicalTrials.gov
    Denosumab Q4W DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Ethanol OTHER Phase PHASE2 Aldehyde Dehydrogenase-2 (ALDH2) Deficiency ClinicalTrials.gov
    Antizol DRUG Phase PHASE2 Aldehyde Dehydrogenase-2 (ALDH2) Deficiency ClinicalTrials.gov
    Cytochrome P450 (CYP) Cocktail DRUG Phase PHASE1 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov
    acapatamab DRUG Phase PHASE1 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov
    Denosumab 60 MG/ML Prefilled Syringe [Prolia] DRUG Phase PHASE2 Premenopausal Idiopathic Osteoporosis ClinicalTrials.gov
    Romosozumab Prefilled Syringe [Evenity] DRUG Phase PHASE2 Premenopausal Idiopathic Osteoporosis ClinicalTrials.gov
    AMG 171 DRUG Phase PHASE1 Obesity ClinicalTrials.gov
    AMG 596 DRUG Phase PHASE1 Glioblastoma or Malignant Glioma ClinicalTrials.gov
    leucovorin calcium DRUG Phase PHASE2 Mucinous Adenocarcinoma of the Colon ClinicalTrials.gov
    fluorouracil DRUG Phase PHASE2 Mucinous Adenocarcinoma of the Colon ClinicalTrials.gov
    irinotecan hydrochloride DRUG Phase PHASE2 Mucinous Adenocarcinoma of the Colon ClinicalTrials.gov
    Standard of care (SOC) DRUG Phase PHASE4 STEMI - ST Elevation Myocardial Infarction ClinicalTrials.gov
    Evolocumab 140 MG/ML DRUG Phase PHASE4 STEMI - ST Elevation Myocardial Infarction ClinicalTrials.gov
    AMG 732 DRUG Phase PHASE1 Thyroid Eye Disease ClinicalTrials.gov
    Ibuprofen/famotidine DRUG Phase PHASE3 Ulcer ClinicalTrials.gov
    Motesanib DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov
    Capecitabine DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov
    Ixabepilone DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov
    Tarlatamab treatment DRUG Phase PHASE2 DLL3-expressing Tumors ClinicalTrials.gov
    Alendronate Effervescent Oral Tablet DRUG Phase PHASE2 Erosive Osteoarthritis ClinicalTrials.gov
    SOX DRUG Phase PHASE1 Gastric Cancer ClinicalTrials.gov
    CAPOX DRUG Phase PHASE1 Gastric Cancer ClinicalTrials.gov
    Methylprednisolone DRUG Phase PHASE2 Allografts ClinicalTrials.gov
    Thymoglobulin DRUG Phase PHASE2 Allografts ClinicalTrials.gov
    Belatacept DRUG Phase PHASE2 Allografts ClinicalTrials.gov
    DMAB Discontinuation and Switching DRUG Phase PHASE4 Osteoporosis ClinicalTrials.gov
    Routine Lipid Management DRUG Phase PHASE4 Cardiovascular Disease ClinicalTrials.gov
    Laboratory Biomarker Analysis OTHER Phase PHASE2 Breast Carcinoma ClinicalTrials.gov
    Bloods and urine OTHER Preclinical Myeloma ClinicalTrials.gov
    DXA scan OTHER Preclinical Myeloma ClinicalTrials.gov
    Diffusion Weighted Magnetic Resonance Imaging (DWMRI) OTHER Preclinical Myeloma ClinicalTrials.gov
    Donor Leukocyte Infusion (DLI) BIOLOGICAL Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Interferon gamma-1b DRUG Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Ibrutinib DRUG Phase PHASE2 Waldenstrom Macroglobulinemia ClinicalTrials.gov
    Carfilzomib + Ibrutinib DRUG Phase PHASE2 Waldenstrom Macroglobulinemia ClinicalTrials.gov
    VIB7734 DRUG Phase PHASE1 Systemic Lupus Erythematosus ClinicalTrials.gov
    Radiotherapy RADIATION Phase PHASE1 Soft Tissue Sarcoma ClinicalTrials.gov
    Questionnaire OTHER Preclinical Psoriatic Arthritis ClinicalTrials.gov
    Nab-paclitaxel DRUG Phase PHASE1 Squamous-Cell Non-Small-Cell Lung Cancer ClinicalTrials.gov
    Pharmacological Study OTHER Phase PHASE1 CD20 Positive ClinicalTrials.gov
    Ifosfamide DRUG Phase PHASE1 CD20 Positive ClinicalTrials.gov
    Extended Consultation for apremilast BEHAVIORAL Phase EARLY_PHASE1 Psoriasis ClinicalTrials.gov
    Reminder Text Intervention with apremilast BEHAVIORAL Phase EARLY_PHASE1 Psoriasis ClinicalTrials.gov
    Otezla - Standard Care DRUG Phase EARLY_PHASE1 Psoriasis ClinicalTrials.gov
    AMG 427 DRUG Phase PHASE1 Relapsed/Refractory Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    Pomalidomide DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Belantamab mafodotin DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    AMG 355 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    AMG 513 DRUG Phase PHASE1 Cardiometabolic Disease ClinicalTrials.gov
    Aeroquin DRUG Phase PHASE3 Cystic Fibrosis ClinicalTrials.gov
    Daratumumab DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Montelukast DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Diphenhydramine DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Acetaminophen DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Bortezomib DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    MR prednisone DRUG Phase PHASE3 Rheumatoid Arthritis ClinicalTrials.gov
    TIS (Tobramycin Inhalation Solution) DRUG Phase PHASE3 Cystic Fibrosis ClinicalTrials.gov
    MEDI7734 BIOLOGICAL Phase PHASE1 Dermatomyositis, Polymyositis, Sjogren's, SLE, SSc ClinicalTrials.gov
    Placebo, twice daily, plus cyclophosphamide/rituximab plus glucocorticoids OTHER Phase PHASE2 ANCA-associated Vasculitis ClinicalTrials.gov
    CCX168 30 mg, twice daily, cyclophosphamide/rituximab plus glucocorticoids DRUG Phase PHASE2 ANCA-associated Vasculitis ClinicalTrials.gov
    CCX168 10 mg, twice daily, plus cyclophosphamide/rituximab plus glucocorticoids DRUG Phase PHASE2 ANCA-associated Vasculitis ClinicalTrials.gov
    Isatuximab BIOLOGICAL Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    HZN-825 QD DRUG Phase PHASE2 Diffuse Cutaneous Systemic Sclerosis ClinicalTrials.gov
    HZN-825 BID DRUG Phase PHASE2 Diffuse Cutaneous Systemic Sclerosis ClinicalTrials.gov
    Ziftomenib DRUG Phase PHASE1 Lymphoblastic Leukemia ClinicalTrials.gov
    Mercaptopurine DRUG Phase PHASE1 Lymphoblastic Leukemia ClinicalTrials.gov
    Vorinostat DRUG Phase PHASE1 Lymphoblastic Leukemia ClinicalTrials.gov
    PEG asparaginase DRUG Phase PHASE1 Lymphoblastic Leukemia ClinicalTrials.gov
    normal saline DRUG Phase PHASE2 Thyroid Associated Ophthalmopathies ClinicalTrials.gov
    Alendronate 70Mg Tab DRUG Phase PHASE3 Bone Density, Low ClinicalTrials.gov
    Romosozumab Prefilled Syringe DRUG Phase PHASE3 Bone Density, Low ClinicalTrials.gov
    Carfilzomib, lenalidomide, dexamethasone (KRd) + Daratumumab DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    BI 1701963 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    IV Chemotherapy (Regimen 2) DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    IV Chemotherapy (Regimen 1) DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    TNO155 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    MVASI® (bevacizumab-awwb) DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Palbociclib DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Carboplatin, pemetrexed, docetaxel, paclitaxel DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Afatinib DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    RMC-4630 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Trametinib DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Avacopan Matching Placebo DRUG Phase PHASE2 C3 Glomerulopathy (C3G) ClinicalTrials.gov
    Digoxin DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov
    AMG 199 DRUG Phase PHASE1 MUC17-positive Solid Tumors ClinicalTrials.gov
    Surgery PROCEDURE Phase PHASE2 Soft Tissue Sarcoma ClinicalTrials.gov
    Neoadjuvant Radiation RADIATION Phase PHASE2 Soft Tissue Sarcoma ClinicalTrials.gov
    Cortancyl DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    Lodotra DRUG Phase PHASE2 Asthma ClinicalTrials.gov
    Blinatumomab 28 ug DRUG Phase PHASE1 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Blinatumomab 9ug DRUG Phase PHASE1 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    EU-authorized Nivolumab DRUG Phase PHASE3 Melanoma ClinicalTrials.gov
    FDA-licensed Nivolumab DRUG Phase PHASE3 Melanoma ClinicalTrials.gov
    VIMOVO 500/20 DRUG Phase PHASE4 Juvenile Idiopathic Arthritis (JIA) ClinicalTrials.gov
    VIMOVO 375/20 DRUG Phase PHASE4 Juvenile Idiopathic Arthritis (JIA) ClinicalTrials.gov
    VIMOVO 250/20 DRUG Phase PHASE4 Juvenile Idiopathic Arthritis (JIA) ClinicalTrials.gov
    Rifampin DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov
    AB248 DRUG Phase PHASE1 Extensive Stage Small Cell Lung Cancer ClinicalTrials.gov
    CCX872-B DRUG Phase PHASE1 Pancreatic Cancer ClinicalTrials.gov
    AMG 119 BIOLOGICAL Phase PHASE1 Small Cell Lung Cancer ClinicalTrials.gov
    Opportunistic screening for low BMD DEVICE Approved Low Bone Density ClinicalTrials.gov
    Placebo 1.7 ml Subcutaneous Solution DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA] DRUG Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Blood tests OTHER Phase PHASE4 Neuromyelitis Optica Spectrum Disorder ClinicalTrials.gov
    RMC-6236 DRUG Phase PHASE1 Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers ClinicalTrials.gov
    Modified FOLFIRINOX DRUG Phase PHASE1 Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers ClinicalTrials.gov
    Placebo (EREN-P) s.c. administered every four weeks for a total of five treatments DRUG Phase PHASE2 Temporomandibular Disorder ClinicalTrials.gov
    Erenumab-aooe (EREN) 140 mg s.c. administered every four weeks for a total of five treatments DRUG Phase PHASE2 Temporomandibular Disorder ClinicalTrials.gov
    Placebo (Normal Saline) DRUG Phase PHASE2 Lupus Nephritis ClinicalTrials.gov
    pioglitazone DRUG Phase PHASE2 Type 2 Diabetes Mellitus ClinicalTrials.gov
    Ponatinib DRUG Phase PHASE2 Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive ClinicalTrials.gov
    Azathioprine DRUG Phase PHASE3 ANCA-Associated Vasculitis ClinicalTrials.gov
    Apremilast (CC-10004) Placebo OTHER Phase PHASE4 Arthritis, Psoriatic ClinicalTrials.gov
    Apremilast (CC-10004) DRUG Phase PHASE4 Arthritis, Psoriatic ClinicalTrials.gov
    Trebananib DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Cetuximab DRUG Phase PHASE2 Cancer of the Colon ClinicalTrials.gov
    ASCT PROCEDURE Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Ustekinumab DRUG Phase PHASE3 Plaque Psoriasis ClinicalTrials.gov
    ABP 654 DRUG Phase PHASE3 Plaque Psoriasis ClinicalTrials.gov
    AMG 256 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Placebo to Alendronate DRUG Phase PHASE3 Postmenopausal Women With Osteoporosis ClinicalTrials.gov
    Placebo to Romosozumab DRUG Phase PHASE3 Postmenopausal Women With Osteoporosis ClinicalTrials.gov
    AMG 378 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Gastro-Retentive (GR) Formulation DRUG Phase PHASE1 Relapsed or Refractory Multiple Myeloma ClinicalTrials.gov
    Immediate Release (IR) Formulation DRUG Phase PHASE1 Relapsed or Refractory Multiple Myeloma ClinicalTrials.gov
    Cysteamine Bitartrate Delayed-release Capsules (RP103) DRUG Phase PHASE3 Cystinosis ClinicalTrials.gov
    Cystagon® (Cysteamine Bitartrate) DRUG Phase PHASE3 Cystinosis ClinicalTrials.gov
    Pegloticase with MTX BIOLOGICAL Phase PHASE4 Chronic Uncontrolled Gout ClinicalTrials.gov
    Lenvatinib DRUG Phase PHASE2 Metastatic Non Small Cell Lung Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Amgen Inc
    • CIK: 0000318154
    • Ticker Symbol: AMGN
    • Period End Date: 2022-10-20
    • Document Type: 8-K

Search

News categories